01 / 20

Dialysis and
Transplant Care

Managing patients with end-stage renal disease: from dialysis modalities to post-transplant immunosuppression and complications.

USMLE Step 3

What Is Renal Replacement Therapy?

When kidneys fail to filter blood adequately (end-stage renal disease, ESRD), waste products and fluid accumulate. Renal replacement therapy (RRT) takes over this filtering role through one of three pathways.

When to Start Dialysis

Acute dialysis indications are remembered by the mnemonic "AEIOU":

A
Acidosis — severe metabolic acidosis (\( pH < 7.1 \)) refractory to medical therapy.
E
Electrolytes — refractory hyperkalemia (\( K^+ > 6.5 \) mEq/L) with ECG changes.
I
Intoxications — dialyzable toxins (methanol, ethylene glycol, salicylates, lithium).
O
Overload — volume overload / pulmonary edema unresponsive to diuretics.
U
Uremia — pericarditis, encephalopathy, or bleeding from uremic platelet dysfunction.

How Hemodialysis Works

Patient blood out Dialyzer semipermeable membrane clean blood + waste dialysate

Hemodialysis vs Peritoneal Dialysis

Hemodialysis (HD)
In-center, 3×/week, ~4 hr sessions. Needs vascular access (AV fistula preferred). More rapid solute clearance.
Peritoneal Dialysis (PD)
Home-based, daily. Uses peritoneum as membrane. No vascular access needed. Risk of PD peritonitis.

Kidney Transplantation

Transplant offers the best survival and quality of life for ESRD patients. Donor matching reduces rejection risk by assessing ABO blood type and HLA (human leukocyte antigen) compatibility.

Living donor
Better graft survival, can be scheduled, often pre-emptive (before dialysis).
Deceased donor
Long waitlist; allocation prioritizes HLA match and waiting time.

Types of Graft Rejection

1
Hyperacute (minutes–hours): preformed anti-donor antibodies. Graft thrombosis. Requires immediate removal.
2
Acute (days–months): cell-mediated (T-cell) or antibody-mediated. Often treatable with steroids / immunosuppression.
3
Chronic (months–years): progressive fibrosis and vascular changes. Generally irreversible.

Approach to Rising Creatinine Post-Transplant

1
Check drug levels. Calcineurin inhibitor (tacrolimus/cyclosporine) toxicity is a common reversible cause.
2
Ultrasound with Doppler to exclude obstruction, fluid collection, and renal artery/vein issues.
3
Consider infection — BK virus nephropathy and CMV can mimic rejection.
4
Allograft biopsy is the gold standard to distinguish rejection from other causes.

Worked Example: Hyperkalemia

1
IV calcium gluconate first — stabilizes the cardiac membrane (does not lower \( K^+ \)).
2
Insulin + glucose and β-agonist shift \( K^+ \) intracellularly.
3
Definitive removal: urgent hemodialysis in this anuric ESRD patient.

Worked Example: PD Peritonitis

This is PD-associated peritonitis. Management:

1
Send effluent for cell count, Gram stain, and culture.
2
Intraperitoneal antibiotics covering gram-positive and gram-negative organisms (e.g., vancomycin + ceftazidime).
3
Catheter removal if refractory, fungal, or relapsing peritonitis.

Worked Example: Tacrolimus Toxicity

The elevated trough plus neurotoxicity (tremor) point to calcineurin inhibitor toxicity, not rejection. Reduce the dose and recheck levels — biopsy is unnecessary when the picture is classic and drug-level driven.

Common Mistakes

✕ Calcium "lowers" potassium
IV calcium stabilizes the myocardium but does NOT reduce serum \( K^+ \). It buys time, not correction.
✕ Biopsy before drug levels
Always check calcineurin inhibitor levels first — toxicity is a common, reversible cause of rising creatinine.
✕ Catheter over fistula
Tunneled catheters have the highest infection risk. AV fistula is the preferred long-term HD access.
✕ Live vaccines post-transplant
Avoid live vaccines in immunosuppressed transplant recipients; give inactivated vaccines instead.

Rejection Summary Table

Hyperacute Acute Chronic
TimingMinutes–hoursDays–monthsMonths–years
MechanismPreformed AbT-cell / AbFibrosis / vascular
Reversible?NoOftenNo
ManagementRemove graftSteroids / immunosupp.Supportive

Immunosuppression & Complications

Lifelong immunosuppression prevents rejection but increases infection and malignancy risk.

Calcineurin inhibitors
Tacrolimus, cyclosporine. Nephrotoxic; narrow therapeutic window.
Antiproliferatives
Mycophenolate. GI upset and cytopenias.
Corticosteroids
Diabetes, osteoporosis, hyperlipidemia.

Question 1 of 5

An anuric HD patient has \( K^+ = 7.4 \) mEq/L with peaked T waves. What is the first intervention?

Question 2 of 5

A graft fails within minutes of vascular anastomosis due to immediate thrombosis. What is the mechanism?

Question 3 of 5

A transplant patient's creatinine rises with a tacrolimus trough of \( 19 \) ng/mL and a fine tremor. Best next step?

Question 4 of 5

Which long-term hemodialysis access has the lowest infection and thrombosis risk?

Question 5 of 5

A PD patient has cloudy effluent with \( \text{WBC} > 100/\mu L \) and \( > 50\% \) neutrophils. Initial treatment?

Key Takeaways

1
Dialysis indications: AEIOU — acidosis, electrolytes, intoxications, overload, uremia.
2
In hyperkalemia, calcium first to protect the heart, then shift and remove \( K^+ \).
3
Transplant rejection: hyperacute (irreversible), acute (treatable), chronic (irreversible).
4
Rising creatinine post-transplant: check drug levels first, then image, then biopsy.